カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の基礎インスリン（持効型インスリン）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Basal Insulin (Long-Acting Insulin) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19169）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19169
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の基礎インスリン（持効型インスリン）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

基礎インスリン（持効型インスリン）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の基礎インスリン（持効型インスリン）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

基礎インスリン（持効型インスリン）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・Lantus、Levemir、Tresiba、Toujeo、Basaglar、Biosimilar Glargines

用途別セグメントは次のように区分されます。
・1型糖尿病、2型糖尿病

世界の基礎インスリン（持効型インスリン）市場の主要な市場プレーヤーは以下のとおりです。
・Novo Nordisk、Sanofi Aventis、Eli Lilly、Biocon、Julphar、Exir、Sedico、Wockhardt

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、基礎インスリン（持効型インスリン）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な基礎インスリン（持効型インスリン）メーカーの企業概要、2019年～2022年までの基礎インスリン（持効型インスリン）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な基礎インスリン（持効型インスリン）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別基礎インスリン（持効型インスリン）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの基礎インスリン（持効型インスリン）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での基礎インスリン（持効型インスリン）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および基礎インスリン（持効型インスリン）の産業チェーンを掲載しています。
・第13、14、15章では、基礎インスリン（持効型インスリン）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 基礎インスリン（持効型インスリン）の概要
- 種類別分析（2017年vs2021年vs2028年）：Lantus、Levemir、Tresiba、Toujeo、Basaglar、Biosimilar Glargines
- 用途別分析（2017年vs2021年vs2028年）：1型糖尿病、2型糖尿病
- 世界の基礎インスリン（持効型インスリン）市場規模・予測
- 世界の基礎インスリン（持効型インスリン）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novo Nordisk、Sanofi Aventis、Eli Lilly、Biocon、Julphar、Exir、Sedico、Wockhardt
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：Lantus、Levemir、Tresiba、Toujeo、Basaglar、Biosimilar Glargines
・用途別分析2017年-2028年：1型糖尿病、2型糖尿病
・基礎インスリン（持効型インスリン）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・基礎インスリン（持効型インスリン）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・基礎インスリン（持効型インスリン）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・基礎インスリン（持効型インスリン）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・基礎インスリン（持効型インスリン）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Basal Insulin (Long-Acting Insulin) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Basal Insulin (Long-Acting Insulin) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Type 1 Diabetes accounting for % of the Basal Insulin (Long-Acting Insulin) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Lantus segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, and Julphar, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Basal Insulin (Long-Acting Insulin) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Lantus
Levemir
Tresiba
Toujeo
Basaglar
Biosimilar Glargines
Market segment by Application can be divided into
Type 1 Diabetes
Type 2 Diabetes
The key market players for global Basal Insulin (Long-Acting Insulin) market are listed below:
Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon
Julphar
Exir
Sedico
Wockhardt
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Basal Insulin (Long-Acting Insulin) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Basal Insulin (Long-Acting Insulin), with price, sales, revenue and global market share of Basal Insulin (Long-Acting Insulin) from 2019 to 2022.
Chapter 3, the Basal Insulin (Long-Acting Insulin) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Basal Insulin (Long-Acting Insulin) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Basal Insulin (Long-Acting Insulin) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Basal Insulin (Long-Acting Insulin).
Chapter 13, 14, and 15, to describe Basal Insulin (Long-Acting Insulin) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Basal Insulin (Long-Acting Insulin) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Basal Insulin (Long-Acting Insulin) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Market Analysis by Application
1.3.1 Overview: Global Basal Insulin (Long-Acting Insulin) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size & Forecast
1.4.1 Global Basal Insulin (Long-Acting Insulin) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales in Volume (2017-2028)
1.4.3 Global Basal Insulin (Long-Acting Insulin) Price (2017-2028)
1.5 Global Basal Insulin (Long-Acting Insulin) Production Capacity Analysis
1.5.1 Global Basal Insulin (Long-Acting Insulin) Total Production Capacity (2017-2028)
1.5.2 Global Basal Insulin (Long-Acting Insulin) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Basal Insulin (Long-Acting Insulin) Market Drivers
1.6.2 Basal Insulin (Long-Acting Insulin) Market Restraints
1.6.3 Basal Insulin (Long-Acting Insulin) Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product and Services
2.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi Aventis
2.2.1 Sanofi Aventis Details
2.2.2 Sanofi Aventis Major Business
2.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product and Services
2.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Product and Services
2.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business
2.4.3 Biocon Basal Insulin (Long-Acting Insulin) Product and Services
2.4.4 Biocon Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Julphar
2.5.1 Julphar Details
2.5.2 Julphar Major Business
2.5.3 Julphar Basal Insulin (Long-Acting Insulin) Product and Services
2.5.4 Julphar Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Exir
2.6.1 Exir Details
2.6.2 Exir Major Business
2.6.3 Exir Basal Insulin (Long-Acting Insulin) Product and Services
2.6.4 Exir Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sedico
2.7.1 Sedico Details
2.7.2 Sedico Major Business
2.7.3 Sedico Basal Insulin (Long-Acting Insulin) Product and Services
2.7.4 Sedico Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Wockhardt
2.8.1 Wockhardt Details
2.8.2 Wockhardt Major Business
2.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Product and Services
2.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Basal Insulin (Long-Acting Insulin) Breakdown Data by Manufacturer
3.1 Global Basal Insulin (Long-Acting Insulin) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Basal Insulin (Long-Acting Insulin)
3.4 Market Concentration Rate
3.4.1 Top 3 Basal Insulin (Long-Acting Insulin) Manufacturer Market Share in 2021
3.4.2 Top 6 Basal Insulin (Long-Acting Insulin) Manufacturer Market Share in 2021
3.5 Global Basal Insulin (Long-Acting Insulin) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Basal Insulin (Long-Acting Insulin) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region
4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales in Volume by Region (2017-2028)
4.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2028)
4.2 North America Basal Insulin (Long-Acting Insulin) Revenue (2017-2028)
4.3 Europe Basal Insulin (Long-Acting Insulin) Revenue (2017-2028)
4.4 Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue (2017-2028)
4.5 South America Basal Insulin (Long-Acting Insulin) Revenue (2017-2028)
4.6 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Basal Insulin (Long-Acting Insulin) Sales in Volume by Type (2017-2028)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Basal Insulin (Long-Acting Insulin) Sales in Volume by Application (2017-2028)
6.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)
6.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
7.2 North America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
7.3 North America Basal Insulin (Long-Acting Insulin) Market Size by Country
7.3.1 North America Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2017-2028)
7.3.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
8.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
8.3 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country
8.3.1 Europe Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2017-2028)
8.3.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
9.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
9.3 Asia-Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region
9.3.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
10.2 South America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
10.3 South America Basal Insulin (Long-Acting Insulin) Market Size by Country
10.3.1 South America Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2017-2028)
10.3.2 South America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)
11.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)
11.3 Middle East & Africa Basal Insulin (Long-Acting Insulin) Market Size by Country
11.3.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Basal Insulin (Long-Acting Insulin) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Basal Insulin (Long-Acting Insulin)
12.3 Basal Insulin (Long-Acting Insulin) Production Process
12.4 Basal Insulin (Long-Acting Insulin) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Basal Insulin (Long-Acting Insulin) Typical Distributors
13.3 Basal Insulin (Long-Acting Insulin) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Basal Insulin (Long-Acting Insulin) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Basal Insulin (Long-Acting Insulin) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product and Services
Table 6. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Aventis Major Business
Table 9. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product and Services
Table 10. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly Basal Insulin (Long-Acting Insulin) Product and Services
Table 14. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biocon Basic Information, Manufacturing Base and Competitors
Table 16. Biocon Major Business
Table 17. Biocon Basal Insulin (Long-Acting Insulin) Product and Services
Table 18. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Julphar Basic Information, Manufacturing Base and Competitors
Table 20. Julphar Major Business
Table 21. Julphar Basal Insulin (Long-Acting Insulin) Product and Services
Table 22. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Exir Basic Information, Manufacturing Base and Competitors
Table 24. Exir Major Business
Table 25. Exir Basal Insulin (Long-Acting Insulin) Product and Services
Table 26. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sedico Basic Information, Manufacturing Base and Competitors
Table 28. Sedico Major Business
Table 29. Sedico Basal Insulin (Long-Acting Insulin) Product and Services
Table 30. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 32. Wockhardt Major Business
Table 33. Wockhardt Basal Insulin (Long-Acting Insulin) Product and Services
Table 34. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Basal Insulin (Long-Acting Insulin), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Basal Insulin (Long-Acting Insulin) Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Basal Insulin (Long-Acting Insulin) Production Site of Key Manufacturer
Table 40. Basal Insulin (Long-Acting Insulin) New Entrant and Capacity Expansion Plans
Table 41. Basal Insulin (Long-Acting Insulin) Mergers & Acquisitions in the Past Five Years
Table 42. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)
Table 43. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2023-2028) & (K Units)
Table 44. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 47. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 48. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Basal Insulin (Long-Acting Insulin) Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Basal Insulin (Long-Acting Insulin) Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 53. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 54. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Basal Insulin (Long-Acting Insulin) Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Basal Insulin (Long-Acting Insulin) Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 59. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 60. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 63. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 64. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 65. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 66. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 67. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 68. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 71. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 72. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 73. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 82. South America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)
Table 83. South America Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)
Table 84. South America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 87. South America Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 88. South America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 89. South America Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)
Table 98. Basal Insulin (Long-Acting Insulin) Raw Material
Table 99. Key Manufacturers of Basal Insulin (Long-Acting Insulin) Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Basal Insulin (Long-Acting Insulin) Typical Distributors
Table 103. Basal Insulin (Long-Acting Insulin) Typical Customers
List of Figures
Figure 1. Basal Insulin (Long-Acting Insulin) Picture
Figure 2. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type in 2021
Figure 3. Lantus
Figure 4. Levemir
Figure 5. Tresiba
Figure 6. Toujeo
Figure 7. Basaglar
Figure 8. Biosimilar Glargines
Figure 9. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application in 2021
Figure 10. Type 1 Diabetes
Figure 11. Type 2 Diabetes
Figure 12. Global Basal Insulin (Long-Acting Insulin) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Basal Insulin (Long-Acting Insulin) Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Basal Insulin (Long-Acting Insulin) Sales (2017-2028) & (K Units)
Figure 15. Global Basal Insulin (Long-Acting Insulin) Price (2017-2028) & (US$/Unit)
Figure 16. Global Basal Insulin (Long-Acting Insulin) Production Capacity (2017-2028) & (K Units)
Figure 17. Global Basal Insulin (Long-Acting Insulin) Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Basal Insulin (Long-Acting Insulin) Market Drivers
Figure 19. Basal Insulin (Long-Acting Insulin) Market Restraints
Figure 20. Basal Insulin (Long-Acting Insulin) Market Trends
Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturer in 2021
Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturer in 2021
Figure 23. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Basal Insulin (Long-Acting Insulin) Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Basal Insulin (Long-Acting Insulin) Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2028)
Figure 27. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2017-2028)
Figure 28. North America Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (USD Million)
Figure 29. Europe Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (USD Million)
Figure 31. South America Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (USD Million)
Figure 33. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 34. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)
Figure 35. Global Basal Insulin (Long-Acting Insulin) Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 37. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)
Figure 38. Global Basal Insulin (Long-Acting Insulin) Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 40. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 41. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2017-2028)
Figure 42. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2017-2028)
Figure 43. United States Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 47. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 48. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2017-2028)
Figure 49. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2017-2028)
Figure 50. Germany Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2017-2028)
Figure 59. China Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 66. South America Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 67. South America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2017-2028)
Figure 68. South America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Basal Insulin (Long-Acting Insulin) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Basal Insulin (Long-Acting Insulin) in 2021
Figure 80. Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
Figure 81. Basal Insulin (Long-Acting Insulin) Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医療用銅管（パイプ）市場2022年：市場規模予測（～2028年）
  • 世界の筋強直性ジストロフィー1型（DM1）市場2022年：市場規模予測（～2028年）
  • 世界のアンチトロンビン（組換え）市場2022年：市場規模予測（～2028年）
  • 世界の血栓活性剤（BCA）市場2022年：市場規模予測（～2028年）
  • 世界のマイクロニードル（極細針）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19169 )"世界の基礎インスリン（持効型インスリン）市場2022年：市場規模予測（～2028年）" (英文：Global Basal Insulin (Long-Acting Insulin) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。